Skip to search formSkip to main contentSkip to account menu

Ralfinamide

Known as: PRIRALFINAMIDE 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Fluorobenzenes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Effects of ralfinamide in models of nerve injury and chemotherapy‐induced neuropathic pain
2016
2016
Synthesis and Evaluation of Novel α-Aminoamides Containing an Indole Moiety for the Treatment of Neuropathic Pain
The α-aminoamide family of sodium ion channel blockers have exhibited analgesic effects on neuropathic pain. Here, a series of… 
2012
2012
Pressor Response to Oral Tyramine and Monoamine Oxidase Inhibition During Treatment with Ralfinamide (NW-1029)
Ralfinamide, an original Na+ channel blocker developed for the treatment of chronic pain, inhibits monoamineoxidase-B with no… 
2010
2010
Disposition and Metabolism of Ralfinamide, a Novel Na-Channel Blocker, in Healthy Male Volunteers
Ralfinamide is an α-aminoamide derivative with ion channel blocking properties, acting both peripherally and centrally through… 
2010
2010
Strategies for making analgesia safer: the role of comparative effectiveness research.
The development of the selective cyclooxygenase 2 (COX-2) inhibitors and their infamous fall from grace accelerated… 
2008
2008
Ralfinamide administered orally before hindpaw neurectomy or postoperatively provided long-lasting suppression of spontaneous neuropathic pain-related behavior in the rat
2007
2007
344 RALFINAMIDE ACTS THROUGH NMDA RECEPTOR COMPLEX: A CENTRAL ROLE FOR CHRONIC PAIN TREATMENT
2007
2007
Effects of Ralfinamide, a Na channel blocker, on firing properties of adult rat dorsal root ganglia nociceptive neurons
Ralfinamaide (RM), a Na+channel blocker, suppresses cyclophosphamide and acetic acid‐induced bladder hyperactivity. It is… 
2005
2005
The anti-nociceptive agent ralfinamide inhibits tetrodotoxin-resistant and tetrodotoxin-sensitive Na+ currents in dorsal root ganglion neurons.
2004
2004
Ralfinamide. Newron Pharmaceuticals.
  • F. Cattabeni
  • IDrugs : the investigational drugs journal
  • 2004
  • Corpus ID: 29361627
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)